Preface |
Introduction to Microorganisms and Antibacterial Chemotherapy / Section 1: |
Microorganisms / 1.1: |
Key points |
Classification / 1.1.1: |
Structure / 1.1.2: |
Antibacterial targets / 1.1.3: |
Bacterial detection and identification / 1.1.4: |
Other than its mode of action, what factors determine the antibacterial activity of a drug? / 1.1.5: |
Bacterial resistance / 1.1.6: |
The 'post-antibiotic age'? / 1.1.7: |
References |
Questions |
Agents Targeting DNA / Section 2: |
Quinolone antibacterial agents / 2.1: |
Discovery / 2.1.1: |
Synthesis / 2.1.2: |
Bioavailability / 2.1.3: |
Mode of action and selectivity / 2.1.4: |
Clinical applications / 2.1.5: |
Adverse drug reactions / 2.1.7: |
Drug interactions / 2.1.8: |
Recent developments / 2.1.9: |
Rifamycin antibacterial agents / 2.2: |
Nitroimidazole antibacterial agents / 2.2.1: |
Mechanisms of resistance / 2.3.1: |
Agents Targeting Metabolic Processes / 2.3.6: |
Sulfonamide antibacterial agents / 3.1: |
Trimethoprim / 3.1.1: |
Agents Targeting Protein Synthesis / 3.2.1: |
Aminoglycoside antibiotics / 4.1: |
Macrolide antibiotics / 4.1.1: |
Tetracycline antibiotics / 4.2.1: |
Chloramphenicol / 4.3.1: |
Oxazolidinones / 4.4.1: |
Agents Targeting Cell-Wall Synthesis / 4.5.1: |
β-Lactam antibiotics / 5.1: |
Glycopeptide antibiotics / 5.1.1: |
Cycloserine / 5.2.1: |
Isoniazid / 5.3.1: |
Daptomycin / 5.4.1: |
Draw interactions / 5.5.1: |
Index / 5.5.9: |
Introduction To Microorganisms And Antibacterial Chemotherapy |
The âÇ post-antibiotic ageâÇÖ? |
Agents Targeting Dna |
Adverse drug reactions and contraindications |
Bioavailability (agwuh and macgowan, 2006) |
b-lactam antibiotics |
Preface |
Introduction to Microorganisms and Antibacterial Chemotherapy / Section 1: |
Microorganisms / 1.1: |